Nuclear Medicine and Molecular Imaging

The Korean Society of Nuclear Medicine (대한핵의학회)
권호 표지

Characteristics of Brain Perfusion in Patients of Parkinson's Disease

파킨슨병 환자의 뇌관류 분석

  • Jeong, Young-Jin (Departments of Nuclear Medicine, Dong-A University College of Medicine) ;
  • Park, Min-Jung (Departments of Neurology, Dong-A University College of Medicine) ;
  • Kim, Jae-Woo (Departments of Neurology, Dong-A University College of Medicine) ;
  • Kang, Do-Young (Departments of Nuclear Medicine, Dong-A University College of Medicine)
  • 정영진 (동아대학교 의과대학 핵의학교실) ;
  • 박민정 (동아대학교 의과대학 신경과학교실) ;
  • 김재우 (동아대학교 의과대학 신경과학교실) ;
  • 강도영 (동아대학교 의과대학 핵의학교실)
  • Published : 2008.02.29
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: It was well known that cerebral blood perfusion is normal or diffusely decreased in the majority of patients with Parkinson's disease (PD). Actually we interpreted brain perfusion SPECT images of PD patients in the clinical situation, we observed various cerebral perfusion patterns in patients with PD. So we performed brain perfusion SPECT to know the brain perfusion patterns of PD patients and the difference of perfusion patterns according to the sex and the age. Also we classified PD patients into small groups based on the brain perfusion pattern. Methods and Materials: Two hundred nineteen patients (M: 70, F: 149, mean age: $62.9{\pm}6.9$ y/o) who were diagnosed as PD without dementia clinically and 55 patients (M:15, F:40, mean age: $61.4{\pm}9.2$ y/o) as normal controls who had no past illness history were performed $^{99m}Tc$-HMP AO brain perfusion SPECT and neuropsychological test. Results: At first, we compared all patients with PD and normal controls. Brain perfusion in left inferior frontal gyrus, left insula, left transverse temporal gyrus, left inferior parietal lobule, left superior parietal lobule, right precuneus, right caudate tail were lower in patients with PD than normal controls. Secondly, we compared male and female patients with PD and normal controls, respectively. Brain perfusion SPECT showed more decreased cerebral perfusion in left hemisphere than right side in both male and female patients compared to normal controls. And there was larger hypoperfusion area in female patients compared with male. Thirdly, we classified patients with PD and normal controls into 4 groups according to the age and compared brain perfusion respectively. In patient below fifties, brain perfusion in both occipitoparietal and left temporal lobe were lower in PD group. As the patients with PD grew older, hypoperfusion area were shown in both frontal, temporal and limbic lobes. Fourthly, We were able to divide patients into small groups based on cerebral perfusion pattern. There was normal cerebral blood perfusion in 32 (14.7%) of 219 patients with PD, decreased perfusion on the frontal lobe in 45 patients (20.6%), the temporal lobe in 39 patients (17.4%), the parietal lobe in 39 patients (17.9%), the occipital lobe in 40 patients (18.3%), diffuse area in 14 patients (6.4%) and unclassified in 10 patients (4.6%). Fifthly, we compared the results of the neuropsychological test and cerebral perfusion pattern. There was no correlation between two tests except visuospatial function. Conclusion: Various perfusion state were found in patients with PD according to the age and sex. Also we were able to classify perfusion state into several groups and compare the neuropsychological test with cerebral perfusion.

목적: 파킨슨병 환자의 뇌혈류는 일반적으로 정상 또는 미만성의 혈류 감소를 보이는 것으로 보고하고 있다. 하지만 임상 상황에서 파킨슨 환자의 뇌관류 SPECT 결과를 판독할 때 다양한 뇌혈류 양상을 보이는 것을 발견할 수 있다. 이에 본 연구에서는 파킨슨병 환자의 뇌혈류 양상을 뇌관류 SPECT와 SPM 프로그램을 이용하여 나이, 성별, 신경심리 검사에 따라 어떤 차이가 있는지 보았고, 뇌혈류 양상을 유사한 형태끼리 나누어 보았다. 대상 및 방법: 치매가 동반되지 않은 파킨슨병으로 진단된 환자 219명(평균 $62.9{\pm}6.9$세, 남자 70명, 여자 140명)과 대조군으로 질병에 대한 과거력이 없는, 55명(평균 $61.4{\pm}9.2$세, 남자 15명, 여자 40명)을 대상으로 $^{99m}Tc$-HMPAO 뇌관류 SPECT를 실시하였고 SPM을 이용하여 환자군 정상 대조군을 비교하였다. 결과: 첫 번째로 전체 대조군에 비해 전체 환자군에서 좌측 하전두이랑, 좌측 뇌섬엽, 자측 가로측두이랑, 좌측 하두정소엽, 좌측 상두정소엽, 우측 쐐기전소엽, 우측 미상핵꼬리에 혈류 감소를 보였다. 두 번째로 성별에 따른 환자군과 정상춘의 비교에서 전반적으로 남, 여 환자 모두 좌반구의 혈류 감소가 우측에 비해 넓은 영역을 보였고, 남자 환자에 비해 여자 환자에서 좀 더 넓은 영역의 혈류 감소를 보였다. 세 번째로 나이에 따른 환자군과 정상군의 비교에서 50세 이하 환자군 에서는 주로 양쪽 후두엽, 두정엽과 좌측 측두엽에 정상인에 비해서 혈류 감소를 보였고 나이가 증가함에 따라 후두엽, 두정엽의 뇌혈류는 정상으로 나타났으며 양쪽 전두엽, 측두엽, 변연엽의 혈류 감소가 주로 관찰되었다. 네 번째로 뇌혈류가 저하되어 있는 영역을 기준으로 환자를 나누었을 때, 전두엽에 주로 감소되어 있는 환자 45명(20.6%) 측두엽에 주로 감소되어 있는 환자 38명(17.4%), 두정엽 39명(17.9%). 후두엽 40명(18.3%), 미만성으로 감소되어 있는 환자 14명(6.4%), 뇌혈류가 정상인 환자 32명(14.7%), 위의 형태로 분류하기 어려운 경우 10명(4.6%)으로 분류할 수 있었다. 마지막으로 신경심리검사에서 유사한 결과를 보이는 환자들끼리 분류하여 뇌혈류를 보았을 때 신경심리검사와 뇌혈류 양상사이에서 시공간 기능 항목 외에 특별한 상관관계는 발견할 수 없었고, 다시 연령별로 환자를 분류하여 신경심리검사결과와 뇌혈류 양상의 관계를 비교하여 보았을 때 일정 부분에서 유사한 양상을 관찰할 수 있었다. 결론: 파킨슨병 환자의 뇌혈류는 성별과 나이에 따라 다양한 국소적 혈류 저하의 소견을 보였고, 뇌혈류 양상에 따라 환자를 분류할 수 있었다.

Keywords

References

  1. Tolosa E, Wenning G, Poewe W. The diagnosis of Parkinson's disease. Lancet Neurol 2006;5:75-86 https://doi.org/10.1016/S1474-4422(05)70285-4
  2. 고창순. 핵의학: 고려의학; 1997. p. 297-300
  3. Owen AM, Doyon J, Dagher A, Sadikot A, Evans AC. Abnormal basal ganglia outflow in Parkinson's disease identified with PET. Implications for higher cortical functions. Brain 1998;121:949-65 https://doi.org/10.1093/brain/121.5.949
  4. Ceballos-Baumann AO. Functional imaging in Parkinson's disease: activation studies with PET, fMRI and SPECT. J Neurol 2003;250:15-23 https://doi.org/10.1007/s00415-003-1103-1
  5. Samuel M, Ceballos-Baumann AO, Boecker H, Brooks DJ, Motor imagery in normal subjects and Parkinson's disease patients: an $H_2^{15}O$ PET study. Neuroreport 2001;26:821-8
  6. Van Laere K, Santens P, Bosman T, De Reuck J, Mortelmans L, Dierckx R. Statistical parametric mapping of $^99m$Tc-ECD SPECT in idiopathic Parkinson's disease and multiple system atrophy with predominant parkinsonian features: correlation with clinical parameters. J Nucl Med 2004;45:933-42
  7. Imon Y, Matsuda H, Ogawa M, Kogure D, Sunohara N. SPECT image analysis using statistical parametric mapping in patients with Parkinson's disease. J Nucl Med 1999;40:1583-9
  8. Lee MC, Bae SK, Lee MH, Chung JK, Koh CS, Roh JK, et al. Quantitative analysis of regional cerebral blood flow using $^99m$Tc-HMPAO SPECT in Parkinson's disease. Korean J Nucl Med 1992;26:251-6
  9. Firbank MJ, Colloby SJ, Burn DJ, McKeith IG, O'Brien JT. Regional cerebral blood flow in Parkinson's disease with and without dementia. Neuroimage 2003;20:1309-19 https://doi.org/10.1016/S1053-8119(03)00364-1
  10. Pizzolato G, Dam M, Borsato N, Saitta B, Da Col C, Perlotto N, et al. 99mTc-HM-PAO SPECT in Parkinson's disease. J Cereb Blood Flow Metab 1988;1:101-8
  11. Matsui H, Udaka F, Miyoshi T, Hara N, Tamura A, Oda M, et al. Brain perfusion differences between Parkinson's disease and multiple system atrophy with predominant parkinsonian features. Parkinsonism Relat Disord 2005;11:227-32 https://doi.org/10.1016/j.parkreldis.2005.01.001
  12. Dujardin K, Defebvre L, Duhamel A, Lecouffe P, Rogelet P, Steinling M, et al. Cognitive and SPECT characteristics predict progression of Parkinson's disease in newly diagnosed patients. J Neurol 2004;251:1383-92 https://doi.org/10.1007/s00415-004-0549-2
  13. Defebvre LJ, Leduc V, Duhamel A, Lecouffe P, Pasquier F, Lamy-Lhullier C, et al. Technetium HMPAO SPECT study in dementia with Lewy bodies, Alzheimer's disease and idiopathic Parkinson's disease. J Nucl Med 1999;40:956-62
  14. Abe Y, Kachi T, Kato T, Arahata Y, Yamada T, Washimi Y, et al. Occipital hypoperfusion in Parkinson's disease without dementia: correlation to impaired cortical visual processing. J Neurol Neurosurg Psychiatry 2003;74:419-22 https://doi.org/10.1136/jnnp.74.4.419
  15. Feigin A, Antonini A, Fukuda M, De Notaris R, Benti R, Pezzoli G, et al. Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism. Mov Disord 2002;17:1265-70 https://doi.org/10.1002/mds.10270
  16. Colloby S, O'Brien J. Functional imaging in Parkinson's disease and dementia with Lewy bodies. J Geriatr Psychiatry Neurol 2004;17:158-63 https://doi.org/10.1177/0891988704267468
  17. Bosman T, Van Laere K, Santens P. Anatomically standardised 99mTc-ECD brain perfusion SPET allows accurate differentiation between healthy volunteers, multiple system atrophy and idiopathic Parkinson's disease. Eur J Nucl Med Mol Imaging 2003;30:16-24 https://doi.org/10.1007/s00259-002-1009-9
  18. Kikuchi A, Takeda A, Kimpara T, Nakagawa M, Kawashima R, Sugiura M, et al. Hypoperfusion in the supplementary motor area, dorsolateral prefrontal cortex and insular cortex in Parkinson's disease. J Neurol Sci 2001;193:29-36 https://doi.org/10.1016/S0022-510X(01)00641-4
  19. Osaki Y, Morita Y, Fukumoto M, Akagi N, Yoshida S, Doi Y. Three-dimensional stereotactic surface projection SPECT analysis in Parkinson's disease with and without dementia. Mov Disord 2005;20:999-1005 https://doi.org/10.1002/mds.20463
  20. Eidelberg D, Moeller JR, Dhawan V, Spetsieris P, Takikawa S, Ishikawa T, et al. The metabolic topography of parkinsonism. J Cereb Blood Flow Metab 1994;14:783-801 https://doi.org/10.1038/jcbfm.1994.99
  21. Hu MT, Taylor-Robinson SD, Chaudhuri KR, Bell JD, Labbe C, Cunningham VJ, et al. Cortical dysfunction in non-demented Parkinson's disease patients: a combined (31)P-MRS and (18)FDGPET study. Brain 2000;123:340-52 https://doi.org/10.1093/brain/123.2.340
  22. Oishi N, Udaka F, Kameyama M, Sawamoto N, Hashikawa K, Fukuyama H. Regional cerebral blood flow in Parkinson disease with nonpsychotic visual hallucinations. Neurology 2005;65:1708-15 https://doi.org/10.1212/01.wnl.0000187116.13370.e0
  23. Mito Y, Yoshida K, Yabe I, Makino K, Hirotani M, Tashiro K, et al. Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson's disease with and without dementia, and Alzheimer's disease. Clin Neurol Neurosurg 2005;107:396-403 https://doi.org/10.1016/j.clineuro.2004.12.005
  24. Bissessur S, Tissingh G, Wolters EC, Scheltens P. rCBF SPECT in Parkinson's disease patients with mental dysfunction. J Neural Transm Suppl 1997;50:25-30
  25. Globus M, Mildworf B, Melamed E. Cerebral blood flow and cognitive impairment in Parkinson's disease. Neurology 1985;35:1135-9 https://doi.org/10.1212/WNL.35.8.1135
  26. Antonini A, De Notaris R, Benti R, De Gaspari D, Pezzoli G. Perfusion ECD/SPECT in the characterization of cognitive deficits in Parkinson's disease. Neurol Sci 2001;22:45-6 https://doi.org/10.1007/s100720170039
  27. Pillon B, Dubois B, Agid Y. Testing cognition may contribute to the diagnosis of movement disorders. Neurology 1996;46:329-34 https://doi.org/10.1212/WNL.46.2.329
  28. Kang Y, Na DL. Seoul Neuropsychological Screening Battery. Incheon: Human Brain Research & Consulting Co.; 2003
  29. Mito Y, Yoshida K, Yabe I, Makino K, Tashiro K, Kikuchi S, et al. Brain SPECT analysis by 3D-SSP and phenotype of Parkinson's disease. J Neurol Sci 2006;241:67-72 https://doi.org/10.1016/j.jns.2005.10.017
  30. Gibb WRG, Lees AJ. A comparison of clinical and pathological features of young- and old-onset Parkinson's disease. Neurology 1998;38:1402-6
  31. Santens P, De Corte T, Vingerhoets G, Van Laere K, Dierckx R, De Reuck J. Regional cerebral blood flow and episodic memory in Parkinson's disease: a single photon emission tomography study. Eur Neurol 2003;49:238-42 https://doi.org/10.1159/000070194